Swiss National Bank purchased a new stake in shares of Everus (NYSE:ECG – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 95,297 shares of the company’s stock, valued at approximately $6,266,000. Swiss National Bank owned about 0.19% of Everus as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Hennessy Advisors Inc. purchased a new stake in Everus during the fourth quarter valued at approximately $31,611,000. US Bancorp DE purchased a new stake in shares of Everus in the 4th quarter worth $28,332,000. Charles Schwab Investment Management Inc. bought a new position in Everus in the 4th quarter worth $27,031,000. Principal Financial Group Inc. bought a new position in Everus in the 4th quarter worth $16,241,000. Finally, M&T Bank Corp purchased a new position in Everus during the fourth quarter valued at $5,147,000.
Everus Stock Down 2.2 %
NYSE ECG opened at $39.32 on Monday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. Everus has a twelve month low of $36.96 and a twelve month high of $77.93. The stock has a 50-day simple moving average of $54.38.
Insider Buying and Selling
In other news, CFO Maximillian J. Marcy bought 1,300 shares of Everus stock in a transaction dated Tuesday, February 25th. The shares were purchased at an average cost of $38.99 per share, with a total value of $50,687.00. Following the completion of the acquisition, the chief financial officer now owns 5,508 shares of the company’s stock, valued at $214,756.92. This trade represents a 30.89 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Edward A. Ryan bought 1,400 shares of the firm’s stock in a transaction that occurred on Tuesday, February 25th. The stock was purchased at an average price of $38.02 per share, for a total transaction of $53,228.00. Following the completion of the transaction, the director now directly owns 14,928 shares of the company’s stock, valued at $567,562.56. This represents a 10.35 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 3,750 shares of company stock worth $153,853.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Stifel Nicolaus decreased their price objective on Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Oppenheimer raised their target price on shares of Everus from $70.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 7th. Finally, Wolfe Research assumed coverage on shares of Everus in a research report on Tuesday, December 3rd. They issued a “peer perform” rating for the company.
Check Out Our Latest Stock Analysis on ECG
Everus Company Profile
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
Further Reading
- Five stocks we like better than Everus
- The Basics of Support and Resistance
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECG – Free Report).
Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.